TRENTON, N.J. (AP) - Sky-high price hikes for EpiPen, the injected emergency medicine for severe allergic reactions to foods and bug bites, have made its maker the latest target for patients and politicians infuriated by soaring drug prices.
The company, Mylan, has a virtual monopoly on epinephrine injectors, potentially life-saving devices used to stop a runaway allergic reaction.
How EpiPen's maker raised prices, and hackles, so much
Aucun commentaire:
Enregistrer un commentaire